This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Fortune 500 Companies Commit To Accelerate Alzheimer's Prevention Research

CEOi, Bank of America, GE Healthcare, Janssen Research and Development and Merck Partner with Banner Alzheimer's Institute to Encourage Enrollment in Alzheimer's Prevention Registry

PHOENIX, Sept. 18, 2013 /PRNewswire-USNewswire/ -- Recognizing the need to accelerate research to prevent Alzheimer's disease and engage consumers, Banner Alzheimer's Institute (BAI) announced a major multi-corporation partnership today. The Global CEO Initiative on Alzheimer's disease (CEOi) and many of its member companies including: Bank of America, GE Healthcare, Janssen Research and Development, LLC., and Merck will partner together to highlight the need for greater research progress, a key emphasis of World Alzheimer's Day this Saturday.

"If we are to stop Alzheimer's by 2025, people with this disease must join the battle by volunteering to test potential new medicines. Thanks to these companies for bringing a way for Americans to raise their hands to volunteer to the attention of their employees," said George Vradenburg, founder and convener of CEOi.

Every year on World Alzheimer's Day, Alzheimer's organizations on every continent focus on raising awareness about the disease and related dementias. This devastating, debilitating and incurable disease affects more than 5.2 million Americans with one new case diagnosed every 68 seconds. By 2050, that number could nearly triple.

"Only by working together can we find ways to prevent Alzheimer's before we lose another generation," said Dr. Eric M. Reiman, CEO of Banner Research and executive director of Banner Alzheimer's Institute. "We are grateful to the CEOi, Bank of America, GE Healthcare, Janssen Research and Development and Merck for their commitment to this important fight."

BAI will be implementing a public service campaign featuring digital public service messages (PSAs) that encourage people to sign up for the Alzheimer's Prevention Registry. The Registry is an online community of people who are interested in making an impact on Alzheimer's research to help stop the disease. It provides regular updates on the latest scientific advances, as well as information on overall brain health. And to overcome one of the biggest obstacles to clinical research, the Registry supports enrollment into a variety of Alzheimer's prevention studies across the country.

BAI created the Alzheimer's Prevention Registry ( www.endALZnow.org) as part of its mission to end the disease through research at its earliest, pre-symptomatic stages. Such work and other studies often must screen 10 to 15 times the number of people needed because most trials require specific criteria for participation, and finding enough participants can delay research significantly.

About Banner Alzheimer's Institute Through its research and care, Banner Alzheimer's Institute (BAI) is dedicated to the goal of ending Alzheimer's disease without losing another generation. It is helping to launch a new era of Alzheimer's research—treatment and prevention at the pre-symptomatic stage—and to establish a new comprehensive model of care. Established in 2006 by Banner Health, one of the country's largest nonprofit health care systems, BAI has a three-fold focus: to conduct revolutionary studies in the detection, treatment and prevention of Alzheimer's; to set a national standard of patient and family care; and to forge scientific collaborations that bring together institutions and disciplines internationally.

The Alzheimer's Prevention Registry is a shared resource for the general research community and organizations nationwide and a resource for anyone interested in the latest advances in Alzheimer's prevention work. It draws on the support of its other partners, the Geoffrey Beene Gives Back Alzheimer's Initiative and the Alzheimer's Research Forum, and the guidance of leading U.S. researchers and advocates, including Drs. Paul Aisen, Marilyn Albert, Jeffrey Cummings, Jennifer Manly, Ronald Petersen, Reisa Sperling and Michael Weiner. The Registry is part of the Alzheimer's Prevention Initiative (API), an international research collaborative.



1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,070.57 -9.57 -0.05%
S&P 500 2,111.93 -5.76 -0.27%
NASDAQ 5,060.8070 -31.2780 -0.61%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs